Strength training after 50: why it matters more than you think

Losing strength is not a foregone conclusion

With age, muscle mass and strength tend to decline, and when the decline becomes marked it is called sarcopenia, a condition the scientific literature treats as a public health problem among older adults. The question here is a different one: what can be done about it, and how well is it documented? Among the interventions studied, strength training is the one with the most randomised evidence behind it. A word of honesty: most sarcopenia studies involve people around 70 and older, often with a diagnosis already made. For people aged 50 to 65 who move well, the data are more indirect, and we keep them separate below.

What the sarcopenia meta-analyses show

The largest review we consulted is a 2023 network meta-analysis in the Journal of Cachexia, Sarcopenia and Muscle (Shen and colleagues): it brings together 42 randomised trials with 3728 people with sarcopenia, median age 72.9 years, median follow-up 12 weeks. According to the authors, resistance exercise (with or without a nutritional intervention) and its combination with aerobic and balance work were among the most effective interventions for quality of life, with standardised mean differences between 0.68 and 1.11 compared with usual care. For grip strength, the combination of resistance, balance and nutrition gave an improvement of 4.19 kg, which stays below the clinical relevance threshold set by the authors (5 kg); for walking speed, resistance plus balance work gained 0.16 m/s, above the 0.1 m/s threshold. In other words the signal is positive, but not every indicator crosses the clinical threshold, and it is only fair to say so.

A second meta-analysis, published in 2021 in BMC Geriatrics (Lu and colleagues), analysed 26 studies with 1191 people with sarcopenia (group mean ages between 60.6 and 89.5 years). Strength training significantly improved knee extension strength and walking speed; mixed training, meaning strength combined with other activities, did the same with smaller effects. Whole-body vibration alone, by contrast, produced no significant changes. The chart shows standardised effects: these are before-after comparisons, often with high heterogeneity between studies, so they should be read as an order of magnitude and not as a promise for any one person.

A 2023 network meta-analysis in Medicine (Geng and colleagues; 30 studies, 2485 middle-aged and older people with sarcopenia) points the same way: comparing seven types of intervention, resistance exercise came out as the most advantageous for muscle mass, strength and physical performance, with a mean difference of 2.58 in grip strength (95% confidence interval 1.06 to 4.07).

After 50, even without a diagnosis

For healthy adults aged 50 to 73, a 2022 review in Sports Medicine (Markov and colleagues; 15 studies, 566 participants) assessed concurrent training, meaning strength plus aerobic endurance, against not training: the effect on muscle strength was moderate (SMD 0.74). Adults over 65 showed a nominally larger improvement (SMD 1.04) than those aged 65 or younger (SMD 0.60), but the authors detected no significant differences between subgroups. The correct message is therefore that strength gains do not stop at a certain age, not that older people gain more. For balance, that review found no significant effects: balance needs to be trained specifically, it cannot be taken for granted.

You do not need sophisticated equipment to begin. A 2022 meta-analysis in the International Journal of Environmental Research and Public Health (Zhao and colleagues; 13 randomised trials in older people with sarcopenia) identified resistance-band training as the most effective mode among those supported by several studies (Hedges' g 0.629; 95% confidence interval 0.090 to 1.168), with sessions of 40 to 60 minutes, more than three times a week, for at least 12 weeks. This describes the protocol used in the studies, not a prescription: the confidence interval is wide and the people involved already had a diagnosis.

How many sets, how many times a week

On dosage the data are less clear-cut than people assume. A 2022 meta-analysis in Sports Medicine (Marques and colleagues; 15 studies, 430 participants aged 57.9 to 70.1, 93% women) compared one set with multiple sets per exercise: multiple sets gave a small but significant advantage for lower-limb strength (SMD 0.29; mean difference 1.91 kg) and muscle quality, while for upper-limb strength, muscle size and functional capacity one set was enough. In Markov's review, the single-factor analysis found larger effects on strength with three sessions a week (SMD 0.91) than with four (0.55), and with 12 weeks (0.87) than with 21 (0.47). These are indirect comparisons between different groups of studies, however, not direct proof that "more" is worse. The cautious reading is that a moderate, consistent and progressive volume is enough to get started.

From data to a plan: technique, progression, medical advice

Studies tell you what works on average; they do not tell you how you are doing. That is why, at this age, supervision has a practical value: setting technique before load, choosing a starting point that matches today's strength and not that of twenty years ago, progressing gradually, and combining strength, balance and, when needed, aerobic work. If you have cardiovascular conditions, osteoporosis, persistent joint pain or take medication, talking to your doctor before starting is always advisable: training is not a substitute for a medical assessment.

Limits to keep in mind: many studies are short (the median follow-up in Shen's review is 12 weeks), quality and consistency across studies vary, and the populations are often older and already have sarcopenia, so the results do not automatically transfer to a fit 52-year-old. No result is guaranteed.